HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Egan, T.M. Articles by Mueller, B.S. Search for Related Content PubMed PubMed Citation Articles by Egan, T.M. Articles by Mueller, B.S. Related Collections Lung - transplantation

Eur J Cardiothorac Surg 2002;22:602-609
© 2002 Elsevier Science NL

Long term results of lung transplantation for cystic fibrosis

Division of Cardiothoracic Surgery, Department of Surgery, University of North Carolina at Chapel Hill, 108 Burnett–Womack Building, UNC, Chapel Hill, NC 27599-7065, USA

Received 18 September 2001; received in revised form 26 April 2002; accepted 17 June 2002.

* Corresponding author. Tel.: +1-919-966-3381; fax: +1-919-966-3475
e-mail: ltxtme{at}med.unc.edu

Objectives: We reviewed our experience with lung transplant for cystic fibrosis (CF) over a 10-year period to identify factors influencing long-term survival. Methods: One hundred and twenty-three patients with CF have undergone 131 lung transplant procedures at our institution; 114 have had bilateral sequential lung transplants (DLTX) and nine have had bilateral lower lobe transplants from living donors. Three patients had retransplant for acute graft failure, and five had late retransplant for bronchiolitis obliterans syndrome (BOS). Kaplan–Meier survival was calculated for the entire cohort and for subsets at higher risk of death to determine factors predicting a better outcome. Results: Actuarial survival for the entire group of DLTX CF patients was 81% at 1 year, 59% at 5 years, and 38% at 10 years. Lobar transplant was associated with a poorer survival (37.5% at 1 and 5 years). Among DLTX patients, colonization with Burkholderia cepacia was present in 22 patients and was associated with poorer outcome (1- and 5-year survival 60 and 36% in B. cepacia patients vs. 86 and 64% in non-cepacia patients). DLTX patients younger than age 20 (n=22) had a similar survival to patients age 20 or older (n=90). Being on a ventilator at the time of transplant was not associated with poorer survival (n=8). BOS affects increasing numbers of survivors with time. Five CF patients have been retransplanted due to BOS with one operative death and 1-year survival of 60%. Conclusions: DLTX has acceptable long term survival in CF adults and children with end stage disease. CF patients colonized with B. cepacia have a worse outcome but transplantation is still warranted.

Key Words: Lung transplant • Cystic fibrosis • Burkholderia cepacia • Lung retransplant • Bilateral lobe transplant

This article has been cited by other articles:

				G Meachery, A De Soyza, A Nicholson, G Parry, A Hasan, K Tocewicz, T Pillay, S Clark, J L Lordan, S Schueler, et al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort Thorax, August 1, 2008; 63(8): 725 - 731. [Abstract] [Full Text] [PDF]

				A. C. Chang, K. M. Chan, R. J. Lonigro, C. L. Lau, V. N. Lama, K. R. Flaherty, R. Florn, A. Pickens, S. Murray, F. J. Martinez, et al. Surgical patient outcomes after the increased use of bilateral lung transplantation J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 532 - 540. [Abstract] [Full Text] [PDF]

				J. S. Ganesh, C. A. Rogers, R. S. Bonser, N. R. Banner, and on behalf of the steering group of the UK Cardioth Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study Eur. Respir. J., June 1, 2005; 25(6): 964 - 969. [Abstract] [Full Text] [PDF]

				T. G. Liou, F. R. Adler, and D. Huang Use of Lung Transplantation Survival Models to Refine Patient Selection in Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1053 - 1059. [Abstract] [Full Text] [PDF]

				C Pinet, P Scillia, M Cassart, M Lamotte, C Knoop, C Melot, and M Estenne Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis Thorax, September 1, 2004; 59(9): 783 - 789. [Abstract] [Full Text] [PDF]

				A. De Soyza, C. D. Ellis, C. M. A. Khan, P. A. Corris, and R. D. de Hormaeche Burkholderia cenocepacia Lipopolysaccharide, Lipid A, and Proinflammatory Activity Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 70 - 77. [Abstract] [Full Text] [PDF]

				M. de Perrot, C. Chaparro, K. McRae, T. K. Waddell, D. Hadjiliadis, L. G. Singer, A. F. Pierre, M. Hutcheon, and S. Keshavjee Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1493 - 1501. [Abstract] [Full Text] [PDF]

				Management of bronchiectasis DTB, December 1, 2003; 41(12): 91 - 96. [Abstract] [Full Text] [PDF]